Avivagen Inc. announced the appointment of James Nickerson, PhD as President of Avivagen. The appointment will be effective immediately. Currently Mr. Nickerson holds the role of Vice President of Business Development and Innovation for Avivagen.

In this role he has been crucial in identifying and establishing a number of the strategic and important customer and distribution partner relationships that are core to Avivagen's ongoing growth and global expansion. He has also been central in finding new applications for the company's OxC-beta™ product in both the animal and human nutrition fields. Upon joining Avivagen in 2007, Mr. Nickerson established Avivagen's Charlottetown biological research facility and directed the research and development program as senior research biologist.

Over the next 15 years he held progressively senior roles within the company, including Director of Biology and Director of Commercialization Science, prior to taking over Business Development and Innovation responsibilities. During this period he also co-authored six scientific papers on Avivagen's oxidized carotenoid technology platform, and is listed as an author on seven patents relating to the company's product.